透過您的圖書館登入
IP:216.73.216.58
  • 期刊
  • OpenAccess

心臟康復治療在冠狀動脈介入治療術後的臨床作用

Clinical Impact of Cardiac Rehabilitation in Patients after Percutaneous Coronary Intervention

摘要


目的:探討心臟康復治療在冠狀動脈介入治療術後患者中的臨床作用。方法:回顧分析174例實施冠狀動脈介入治療術冠心病患者的臨床資料,根據術後是否參加心臟康復治療分為治療組(84例)和對照組(90例),均給予常規冠心病二級藥物預防治療及健康教育,治療組給予6週共12次心臟康復運動治療,比較兩組患者術後心功能、主要不良心血管事件(MACE)、血脂、血糖等指標,比較治療組患者心臟康復治療3個月前後的心功能、6分鐘步行距離(6MWT)、血脂、血糖、體重指數(BMI)等指標。結果:干預3個月,治療組BMI、LDL、FPG、LVDd均較出院前減低(P<0.05);治療組LVEF、6MWT較出院前提高(P<0.05);治療組LDL、FPG及LVDd的減低優於對照組(P<0.05);治療組LVEF的提高優於對照組(P<0.05);兩組術後3月內均無MACE發生。結論:冠狀動脈介入治療術後給予心臟康復治療可以減低患者的危險因素,改善心功能,提高活動耐力。

並列摘要


Objective: To investigate the clinical impact of cardiac rehabilitation in patients after percutaneous coronary intervention (PCI). Methods: PCI patients with coronary artery disease were retrospectively collected from April 2017 to March 2019. 84 received cardiac rehabilitation. Routine medicine therapy for CHD and health education were given to all patients. In cardiac rehabilitation group, additional 12 times exercise rehabilitation were given for 6 weeks. The cardiac function, MACE, 6MWT, BMI and blood tests were compared before and after treatment. Results: After cardiac rehabilitation for 3 months, the patients in cardiac rehabilitation group had significantly lower levels of BMI, LDL, FPG andLVDdcompared to the values before discharge from hospital (P<0.05), and had significant improvements in LVEF and 6MWT as well. Treatment group patients showedsignificantly more lowering in LDL, FPG and LVDd than the control group patients. The increase inLVEF was also more prominent in treatment group than control group (P<0.05), although both groups showed increase in value. No MACE occurred in either group. Conclusion: Cardiac rehabilitation could reduce the risk factors and improve the cardiac function and activity tolerance inpatients after PCI.

延伸閱讀